Using procalcitonin to guide antimicrobial duration in sepsis: Asking the same questions will not bring different answers

Critical Care

Volumn 18, Issue 3, 2014, Pages

  Salluh, Jorge I F ^a,b   Nobre, Vandack ^c   Povoa, Pedro ^d  

^a D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^b INSTITUTO NACIONAL DE CÂNCER   (Brazil)

^c FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^d UNIVERSIDADE NOVA DE LISBOA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BIOLOGICAL MARKER; PROCALCITONIN; ANTIINFECTIVE AGENT; CALCITONIN; GLYCOPROTEIN; PROTEIN PRECURSOR;

ANTIMICROBIAL THERAPY; CRITICALLY ILL PATIENT; DRUG USE; HUMAN; NOTE; PRIORITY JOURNAL; SEPSIS; SEPTIC SHOCK; TREATMENT DURATION; BLOOD; SHOCK, SEPTIC;

ANTI-BACTERIAL AGENTS; CALCITONIN; GLYCOPROTEINS; HUMANS; PROTEIN PRECURSORS; SEPSIS; SHOCK, SEPTIC;

EID: 84900319781     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc13870     Document Type: Note

References (12)

1. Prkno A, Wacker C, Brunkhorst FM, Schlattman P. Procalcitonin-guided therapy in intensive care unit patients with severe sepsis and septic shock - a systematic review and meta-analysis. Crit Care 2014, 17:R291.
2. Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, Vincent JL, Townsend S, Lemeshow S, Dellinger RP. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis 2012, 12:919-924. 10.1016/S1473-3099(12)70239-6, 23103175.
3. Póvoa P, Salluh JIF. Biomarker-guided antibiotic therapy in adult critically ill patients: a critical review. Ann Intensive Care 2012, 2:32. 10.1186/2110-5820-2-32, 3475044, 22824162.
4. Svoboda P, Kantorová I, Scheer P, Radvanova J, Radvan M. Can procalcitonin help us in timing of re-intervention in septic patients after multiple trauma or major surgery?. Hepatogastroenterology 2007, 54:359-363.
5. Bouadma L, Luyt CE, Tubach F, Cracco C, Alvarez A, Schwebel C, Schortgen F, Lasocki S, Veber B, Dehoux M, Bernard M, Pasquet B, Régnier B, Brun-Buisson C, Chastre J, Wolff M, . PRORATA trial group Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet 2010, 375:463-474. 10.1016/S0140-6736(09)61879-1, 20097417, PRORATA trial group.
6. Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S, . PneumA Trial Group Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial. JAMA 2003, 290:2588-2598. 10.1001/jama.290.19.2588, 14625336, PneumA Trial Group.
7. Micek ST, Ward S, Fraser VJ, Kollef MH. A randomized controlled trial of an antibiotic discontinuation policy for clinically suspected ventilator-associated pneumonia. Chest 2004, 125:1791-1799. 10.1378/chest.125.5.1791, 15136392.
8. Oliveira CF, Botoni FA, Oliveira CR, Silva CB, Pereira HA, Serufo JC, Nobre V. Procalcitonin versus C-reactive protein for guiding antibiotic therapy in sepsis: a randomized trial. Crit Care Med 2013, 41:2336-2343. 10.1097/CCM.0b013e31828e969f, 23921272.
9. Corona A, Wilson APR, Grassi M, Singer M. Short-course monotherapy strategy for treating bacteremia in the critically ill. Minerva Anestesiol 2006, 72:841-857.
10. Coelho LM, Salluh JI, Soares M, Bozza FA, Verdeal JC, Castro-Faria-Neto HC, Silva JR LE, Bozza PT, Póvoa P. Patterns of C-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Crit Care 2012, 16:R53. 10.1186/cc11291, 3681380, 22449513.
11. Póvoa P, Souza-Dantas VC, Soares M, Salluh JI. C-reactive protein in critically ill cancer patients with sepsis: influence of neutropenia. Crit Care 2011, 15:R129. 10.1186/cc10242, 3218995, 21595932.
12. Charles PE, Tinel C, Barbar S, Aho S, Prin S, Doise JM, Olsson NO, Blettery B, Quenot JP. Procalcitonin kinetics within the first days of sepsis: relationship with the appropriateness of antibiotic therapy and the outcome. Crit Care 2009, 13:R38. 10.1186/cc7751, 2689475, 19291325.